- Previous Close
13.76 - Open
13.65 - Bid 13.55 x 40000
- Ask 13.58 x 40000
- Day's Range
13.56 - 13.65 - 52 Week Range
12.10 - 14.99 - Volume
5,819 - Avg. Volume
107,576 - Market Cap (intraday)
48.554B - Beta (5Y Monthly) 0.30
- PE Ratio (TTM)
15.27 - EPS (TTM)
0.89 - Earnings Date Feb 13, 2025
- Forward Dividend & Yield 0.67 (4.90%)
- Ex-Dividend Date Jun 28, 2024
- 1y Target Est
11.00
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical Business, and Processed Food Business. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products, such as frozen udon noodles, packed rice, and frozen okonomiyaki; bakery products; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was incorporated in 1985 and is headquartered in Tokyo, Japan.
www.jt.comRecent News: JAPAY
View MorePerformance Overview: JAPAY
Trailing total returns as of 12/16/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: JAPAY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: JAPAY
View MoreValuation Measures
Market Cap
48.55B
Enterprise Value
48.82B
Trailing P/E
15.26
Forward P/E
11.61
PEG Ratio (5yr expected)
1.10
Price/Sales (ttm)
2.39
Price/Book (mrq)
1.66
Enterprise Value/Revenue
2.42
Enterprise Value/EBITDA
8.07
Financial Highlights
Profitability and Income Statement
Profit Margin
15.69%
Return on Assets (ttm)
5.94%
Return on Equity (ttm)
12.17%
Revenue (ttm)
3.08T
Net Income Avi to Common (ttm)
482.69B
Diluted EPS (ttm)
0.89
Balance Sheet and Cash Flow
Total Cash (mrq)
895.66B
Total Debt/Equity (mrq)
28.11%
Levered Free Cash Flow (ttm)
202.01B